Compare MCK & ARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCK | ARM |
|---|---|---|
| Founded | 1833 | 1990 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.7B | 132.3B |
| IPO Year | 1995 | 2023 |
| Metric | MCK | ARM |
|---|---|---|
| Price | $888.26 | $131.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 22 |
| Target Price | ★ $930.23 | $162.85 |
| AVG Volume (30 Days) | 576.2K | ★ 3.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ 14.87 | N/A |
| EPS | ★ 24.73 | N/A |
| Revenue | ★ $112,084,000,000.00 | N/A |
| Revenue This Year | $14.97 | $23.63 |
| Revenue Next Year | $8.20 | $20.59 |
| P/E Ratio | ★ $36.53 | $169.67 |
| Revenue Growth | ★ 3.11 | N/A |
| 52 Week Low | $637.00 | $80.00 |
| 52 Week High | $999.00 | $183.16 |
| Indicator | MCK | ARM |
|---|---|---|
| Relative Strength Index (RSI) | 38.62 | 62.34 |
| Support Level | $796.22 | $126.01 |
| Resistance Level | $895.58 | $134.58 |
| Average True Range (ATR) | 23.25 | 5.14 |
| MACD | -10.07 | 0.99 |
| Stochastic Oscillator | 10.09 | 71.22 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Arm Holdings is the IP owner and developer of the ARM architecture, which is used in 99% of the world's smartphone CPU cores, and it also has high market share in other battery-powered devices like wearables, tablets, or sensors. Arm licenses its architecture for a fee, offering different types of licenses depending on the flexibility the customer needs. Customers like Apple or Qualcomm buy architectural licenses, which allow them to modify the architecture and add or delete instructions to tailor the chips to their specific needs. Other clients directly buy off-the-shelf designs from Arm. Both off-the-shelf and architectural customers pay a royalty fee per chip shipped.